ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1865

A Rare Case of Calcitriol-Mediated Hypercalcemia in Metastatic Gastrointestinal Stromal Tumor (GIST)

Session Information

Category: Onco-Nephrology

  • 1500 Onco-Nephrology

Authors

  • Khan, Iman Sajid, Weill Cornell Medicine, New York, New York, United States
  • Gutgarts, Victoria, Memorial Sloan Kettering Cancer Center, New York, New York, United States
  • Kirchhoff, Daniel, Memorial Sloan Kettering Cancer Center, New York, New York, United States
  • Ramanathan, Lakshmi V., Memorial Sloan Kettering Cancer Center, New York, New York, United States
  • Shingarev, Roman A., Cleveland Clinic, Cleveland, Ohio, United States
Introduction

Hypercalcemia accompanies 10-30% of malignancies. Calcitriol production accounts for <1% cases, usually with lymphoma, but has been reported with solid tumors.

Case Description

A 62 year old male with GIST with liver involvement was admitted for an elevated calcium (Ca) of 13.9 mg/dL & AKI with creatinine (Cr) 2.2 mg/dL. Diagnosed with GIST 3 years prior, he was treated with imatinib & an investigational mitogen-activated protein kinase enzyme inhibitor. Due to disease progression, he was switched to sunitinib 1 week prior to admission and endorsed taking 100,000 IU of OTC vitamin D tablets daily for perceived immunologic benefits.
Further workup showed bland urinalysis & fractional sodium excretion of 2.6%. Renal sonogram was normal. AKI was ascribed to hypercalcemia-mediated vasoconstriction & renal blood flow reduction. He had an ionized Calcium 6.6 mg/dL (nl: 4.8-5.3 mg/dL), appropriately low PTH & PTHrP 0.9 pmol/L (nl ≤4.2 pmol/L). The 25(OH) vitamin D was reported at >156 ng/mL, then quantified at 240 ng/mL. Calcitriol was elevated at 71 pg/mL (nl: 18-64 pg/nL). Etiology of hypercalcemia was thought to be from excess vitamin D intake. Cr & Ca improved with hydration, calcitonin & pamidronate. He was readmitted with recurrent hypercalcemia, persistently high 25(OH) vitamin D & calcitriol. Suspected to be tumor-mediated, prednisone was added to suppress conversion of 25(OH) vitamin D to calcitriol. Over a 3-week prednisone taper, Ca, Cr, 25(OH) vitamin D, calcitriol normalized.

Discussion

In kidneys, 1 alpha hydroxylase converts 25(OH) vitamin D to calcitriol causing Ca retention. This occurs autonomously in lymphomas & granulomatous diseases causing hypercalcemia. Our case is unique as it (a) describes calcitriol mediated hypercalcemia associated with GIST, (b) highlights that hypercalcemia in malignancy can be multifactorial & in our case was from excess vitamin D intake & elevated calcitriol levels.

Timeline of Events